Global
About Us
About Us
At a glance
Our journey through time
Making in India
Sanofi India Leadership Team
Chasing Miracles of Science
Chasing Miracles of Science
Protecting with vaccines
Solutions in Diabetes
Fighting rare diseases
Dare to Know Epilepsy
Transforming lives with transplantation
Change AD
Our Science
Our Science
Clinical Trials & Results
Clinical Trials & Results
Multiple Sclerosis
Pharmaceutical products
Vaccines
Specialty Care Products
For healthcare professionals
Social Impact
Social Impact
Access to health
Engaged communities
Environmental impact
Ethics & transparency
Consumer Healthcare
Consumer Healthcare
Health & well-being
Consumer Healthcare Leadership
Consumer Healthcare Products
Consumer Healthcare Products
All Products
Dulcoflex® - Constipation Relief Brand
For healthcare professionals
Investors
Investors
Our Business
Board of Directors and Leadership Team
Financial Results
Annual Reports
AGM
Investor Information
Disclosures Under Reg-46 of the Listing Regulations
CSR
Shareholder Corner
Media
Media
Media Release
Media
Media
Press Releases
Company statements
Investors
Investors
Board of Directors and Leadership Team
Board of Directors and Leadership Team
Board of Directors
Board Committees
Sanofi India Limited Leadership Team
Financial Results
Annual Reports
AGM
Scheme of Arrangement
Investor Information
Investor Information
Shareholding pattern
Corporate Governance
Analyst / Investor Meet
Postal Ballot
Secretarial Compliance Report
Related Party Disclosures
Annual Return
Stock Exchange Announcement and Disclosures
Newspaper Advertisement
Disclosures Under Reg. 46 of the Listing Regulations
Disclosures Under Reg. 46 of the Listing Regulations
Our Business
Letter of Appointment of Independent Directors
Composition of Board Committee
Code of Conduct and Policies
Familiarization Programme
Contact information for grievance redressal
Notice of Board Meeting
Financial results
Annual Reports
Shareholding Pattern
Analyst Meet
Notice given to shareholders by way advertisement
Audited Financial Results of Subsidiary
Secretarial Compliance Report
Policy for Determination of Materiality
KMP authorized for Determination of Materiality
Disclosures under Reg. 30 of the Listing Regulations
Annual Return
CSR
Shareholder’s Corner
Shareholder’s Corner
Unclaimed dividends
Unclaimed shares
Investor services
Contact Us
Careers
Careers
Hyderabad Hub
Contact Us
India
Investors
Investor Information
Stock Exchange Announcement and Disclosures
Stock Exchange Announcement and Disclosures
2024
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2024
Intimation for Closure of Trading Window (PDF • 2024)
Resignation of Senior Management Personnel (2024) (PDF • 2024)
Clarification on appointment of Independent Directors by Sanofi Consumer Healthcare India Limited (PDF • 2024)
Appointment of Independent Directors by Sanofi Consumer Healthcare India Limited (PDF • 2024)
2023
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2023
Intimation for Closure of Trading Window (PDF • Sept 2023)
Change in Directorate (PDF • Sept 2023)
Intimation for Closure of Trading Window (PDF • Sept 2023)
Investor / Analyst Meet Transcript 11.05.2023 (PDF • May 2023)
Communication Of Deduction Of Tax At Source On Dividend (PDF • April 2023)
Announcement Under Regulation 30 - NLEM Communication (PDF • April 2023)
Recording of Investor / Analyst Call - May 2023
Recording of Investor / Analyst Call - Feb 2023
2022
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2022
Intimation of Closure of Trading Window (PDF • December 23 2022)
Intimation of Closure of Trading Window (PDF • September 2022)
Board approves One Time Special Interim Dividend (PDF • 2022-07-26)
Interim Dividend and Record Date (PDF • 2022-07-13)
Intimation of Closure of Trading Window (PDF • June 27 2022)
Intimation of Closure of Trading Window (PDF • March 28 2022)
Secretarial Compliance Report for year ended 31st December 2021 (PDF • 2022-03-08)
Re-appointment of Statutory Auditors (PDF • 2022-02-23)
Dividend, AGM Date & Book Closure Date (PDF • 2022-02-23)
Update on Divestment of Soframycin® and Sofradex® businesses – Completion of the Transaction (PDF • 2022-01-31)
2021
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2021
Slump Sale and transfer of the Nutraceuticals business of the Company (PDF • September 30, 2021)
AGM and E-voting Publication (PDF • April 01, 2021)
AGM through Video Conferencing Facility (PDF • March 16, 2021)
Appointment / Re-appointment of Directors, Re-appointment of Chairman (PDF • February 24, 2021)
Final Dividend, AGM & Book Closure (PDF • February 24, 2021)
Proposed divestment of Soframycin® and Sofradex® businesses (PDF • February 05, 2021)
2020
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2020
Appointment of Directors (PDF • July 28, 2020)
Press Release - Sanofi India Launches ‘Allergy Free’ (PDF • June 30, 2020)
AGM & E-voting Publication (PDF • June 12, 2020)
Closing of Transaction - Transfer of Ankleshwar Site to Zentiva (PDF • May 29, 2020)
AGM through Video Conferencing Facility (PDF • May 28, 2020)
AGM, Book Closure and Dividend Payment Date (PDF • May 19, 2020)
Cessation of the term as Independent Director – Mr. Rangaswamy R. Iyer (PDF • March 31, 2020)
Change in Closing date for transaction related to Slump Sale and transfer of Manufacturing Facility at Ankleshwar (PDF • March 27, 2020)
Change in Annual General Meeting (AGM) Date & Book Closure Date (PDF • March 23, 2020)
Final Dividend, AGM & Book Closure (PDF • February 25, 2020)
Resignation of Non Executive Directors (PDF • February 25, 2020)
2019
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2019
Sanofi India Limited to sell Ankleshwar site to Zentiva (PDF • September 11, 2019)
Appointment of Additional Director and Whole Time Director (PDF • July 29, 2019)
AGM & E-Voting Publication (PDF • April 11, 2019)
Directorate of Health Services (Government of Goa) and Sanofi India join hands to reduce diabetes burden on the State’s health exchequer (PDF • February 1, 2019)
Combiflam® ICYHOT™ takes on ‘strong pain’ in its new ad campaign created by Ogilvy (PDF • January 21, 2019)
2018
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2018
Press Release - Combiflam® Range of Pain Relief Solutions introduces Pain Education Campaign in Bihar (PDF • October 10, 2018)
26 young people with type 1 diabetes successfully surmount 13,000 ft., in ‘India’s 2nd T1D Challenge 2018’ (PDF • September 18, 2018)
Resignation of Non – Executive Director (PDF • July 25, 2018)
Interim Dividend 2018 & Record Date (PDF • July 25, 2018)
Appointment of Additional Director and Whole Time Director (PDF • July 25, 2018)
Board to Consider Interim Dividend on 25th July 2018 (PDF • July 19, 2018)
Press Release - Combiflam® Range of Pain Relief Solutions launches Pain Education Campaign (PDF • July 11, 2018)
AGM & E-voting Publication (PDF • April 11, 2018)
Notice of AGM to be held on 08.05.2018 (PDF • April 10, 2018)
Final Dividend, AGM & Book Closure (PDF • February 22, 2018)
Sanofi launches new insulin Toujeo ™ in India (PDF • February 12, 2018)
Resignation of Independent Director (PDF • January 15, 2018)
Authorized officials for disclosure of material information to Stock Exchanges (PDF • January 15, 2018)
2017
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2017
Sanofi India Limited appoints N. Rajaram as Managing Director (PDF • December 15, 2017)
Re-organization of the Board (PDF • December 15, 2017)
Sanofi Launches ‘Combiflam® ICYHOT™’ Pain Relief Topical in India - 11.09.2017 (PDF • September 11, 2017)
Publication of Record date (PDF • July 21, 2017)
Declaration of Dividend and Record Date (PDF • July 19, 2017)
AGM Publication - 08.04.2017 (PDF • April 10, 2017)
Clarification on News Article www.reuters.com - 29.03.2017 (PDF • April 06, 2017)
Clarification on news article - 03.03.2017 (PDF • April 06, 2017)
Notice of AGM to be held on 05.05.2017 (PDF • April 06, 2017)
Appointment of Statutory Auditors - 27.02.2017 (PDF • February 27, 2017)
Outcome of Boad Meeting - Dividend,AGM,Book closure - 27.02.2017 (PDF • February 27, 2017)
Change in Directors - 27.02.2017 (PDF • February 27, 2017)
Authorized officials for disclosure of Material information to stock exchange (PDF • January 04, 2017)
2016
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2016
Sanofi India collaborates with National Institute of Pharmaceutical Education and Research (NIPER) Kolkata, to promote academic excellence and research (PDF • November 17, 2016)
SIL -Letter to Stock Exchanges – Change in Company Secretary, Compliance Officer and Key Managerial Personnel - 07.11.2016 (PDF • November 07, 2016)
SIL-Letter to Stock Exchanges- Record Date- Interim Dividend for y.e.31.12.2016 (PDF • July 22, 2016)
Outcome of Board Meeting - 02.06.2016 (PDF • June 02, 2016)
Chairman of the Board of Directors - 02.06.2016 (PDF • June 02, 2016)
SIL-Press Release- Chairman of the Board of Directors 02.06.2016 (PDF • June 02, 2016)
Company statement on the recall of Combiflam batches - 23.05.2016 (PDF • May 23, 2016)
Clarifications on news article Combiflam - 12.05.2016 (PDF • May 12, 2016)
Clarification on appointment of Alternate Directors - 03.05.2016 (PDF • May 03, 2016)
Draft Articles of Association proposed for adoption at AGM 29.04.2016 (PDF • April 29, 2016)
Closure of Register of Members - Final Dividend 2015 - 23.03.2016 (PDF • March 29, 2016)
Letter to the Stock Exchanges- Press Release dated 23rd March 2016 (PDF • March 23, 2016)
Manufacture and sale of fixed dose combinations - 23.03.2016 (PDF • March 23, 2016)
Outcome of Board Meeting held - 23.03.2016 (PDF • March 23, 2016)
2015
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2015
Clarification on news item appearing in "Business Standard" - 11.12.2015 (PDF • 2015-12-11)
Re-appointment of Dr. Shailesh Ayyangar as Managing Director - 20.10.2015 (PDF • 2015-10-20)
Appointment of Alternate Directors - 20.10.2015 (PDF • 2015-10-20)
Appointment of Chief Financial Officer - 23.07.2015 (PDF • 2015-07-23)
Changes in Board of Directors - 23.07.2015 (PDF • 2015-07-23)
Interim Dividend for year ending 31st December 2015 - 21.07.2015 (PDF • 2015-07-21)
Sale of building owned by the Company in Andheri, Mumbai 21.07.2015 (PDF • 2015-07-21)
Report on order of CCI - 08.06.2015 (PDF • 2015-06-08)
Notice of Change of Registered Office - 30.03.2015 (PDF • 2015-03-30)